InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
0.00%
)
US TECH 100
17,012.00
(
0.90%
)
Dow Jones
37,903.29
(
0.00%
)
Brent Oil
84.10
(
0.66%
)
Bitcoin
58,848.07
(
1.05%
)
Post# of 251673
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dangerM post# 223441

Monday, 09/30/2019 5:21:15 PM

Monday, September 30, 2019 5:21:15 PM

Post# of 251673
NLNK reverse-merges into Lumos Pharma:

https://www.globenewswire.com/news-release/2019/09/30/1922893/0/en/NewLink-Genetics-and-Lumos-Pharma-Enter-into-Merger-Agreement-to-Form-Biopharmaceutical-Company-Focused-on-Developing-Therapies-to-Treat-Rare-Diseases.html

NewLink Genetics Corporation (NASDAQ:NLNK) and Lumos Pharma, Inc., a private clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare diseases, today announced that the companies have entered into a definitive merger agreement.

Under the terms of the agreement, NewLink will issue Lumos Pharma stockholders NewLink common stock in exchange for their shares in Lumos such that Lumos Pharma stockholders will own approximately 50% of NewLink.

…NewLink will be renamed “Lumos Pharma, Inc.” and will trade on Nasdaq under the symbol “LUMO.”

CC tomorrow (Tuesday) at 8am ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up